UNSPSC 51263700: Adrenergic blocking agent isoquinolines

This classification denotes adrenergic blocking agents based on a group of compounds with the heterocyclic ring structure of benzo(c)pyridine.

UNSPSC 51263700 Adrenergic blocking agent isoquinolines is a Class code that, based on recent state and local opportunities, encompasses procurement of pharmaceutical products including naloxone and related drug-intervention systems for public health and emergency response programs. State and local health departments, county community health agencies, and state human services commissions solicit under this code to stock naloxone for overdose response and to evaluate direct-to-manufacturer pharmaceutical procurement models that bypass traditional pharmacy benefit managers and wholesalers. The work ranges from straightforward product purchases with quarterly delivery schedules to exploratory market-research initiatives that assess vendors' capacity to establish direct contracting relationships with state agencies and self-insured health plans.

Recent activity includes Seminole County, Florida issuing an IFB (solicitation IFB60459723LAS, posted June 30, 2026, response due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, and the Texas Health and Human Services Commission issuing a Request for Information (RFI HHS0017013, posted April 3, 2026) to solicit vendor capabilities regarding direct-to-manufacturer prescription programs and negotiated net pricing models outside traditional pharmacy benefit manager arrangements. Both opportunities target the Southeast and South regions. The Seminole County procurement requires compliance with E-Verify, drug-free workplace certification, and carries an initial two-year term with a one-year renewal option; the Texas RFI functions as a preliminary information-gathering phase to inform future formal procurement strategy and contracting approach.